Abstract:Abstract Background Alternative splicing isoforms have been reported as a new and robust class of diagnostic biomarkers. Over 95% of human genes are estimated to be alternatively spliced as a powerful means of producing functionally diverse proteins from a single gene. The emergence of next-generation sequencing technologies, especially RNA-seq, provides novel insights into large-scale detection and analysis of alternative splicing at the transcriptional level. Advances in Proteomic Technologies such as liquid chromatography coupled tandem mass spectrometry (LC–MS/MS), have shown tremendous power for the parallel characterization of large amount of proteins in biological samples. Although poor correspondence has been generally found from previous qualitative comparative analysis between proteomics and microarray data, significantly higher degrees of correlation have been observed at the level of exon. Combining protein and RNA data by searching LC–MS/MS data against a customized protein database from RNA-Seq may produce a subset of alternatively spliced protein isoform candidates that have higher confidence. Results We developed a bioinformatics workflow to discover alternative splicing biomarkers from LC–MS/MS using RNA-Seq. First, we retrieved high confident, novel alternative splicing biomarkers from the breast cancer RNA-Seq database. Then, we translated these sequences into in silico Isoform Junction Peptides , and created a customized alternative splicing database for MS searching. Lastly, we ran the Open Mass spectrometry Search Algorithm against the customized alternative splicing database with breast cancer plasma proteome. Twenty six alternative splicing biomarker peptides with one single intron event and one exon skipping event were identified. Further interpretation of biological pathways with our Integrated Pathway Analysis Database showed that these 26 peptides are associated with Cancer, Signaling, Metabolism, Regulation, Immune System and Hemostasis pathways, which are consistent with the 256 alternative splicing biomarkers from the RNA-Seq. Conclusions This paper presents a bioinformatics workflow for using RNA-seq data to discover novel alternative splicing biomarkers from the breast cancer proteome. As a complement to synthetic alternative splicing database technique for alternative splicing identification, this method combines the advantages of two platforms: mass spectrometry and next generation sequencing and can help identify potentially highly sample-specific alternative splicing isoform biomarkers at early-stage of cancer.

regulAS: A Bioinformatics Tool for the Integrative Analysis of Alternative Splicing Regulome using RNA-Seq data

SpliceTools, a Suite of Downstream RNA Splicing Analysis Tools to Investigate Mechanisms and Impact of Alternative Splicing

ASAS-EGB: A statistical framework for estimating allele-specific alternative splicing events using transcriptome data.

ASpedia-R: a package to retrieve junction-incorporating features and knowledge-based functions of human alternative splicing events

SpliceWiz: interactive analysis and visualization of alternative splicing in R

OncoSplicing 3.0: an Updated Database for Identifying RBPs Regulating Alternative Splicing Events in Cancers.

LncAS2Cancer: a Comprehensive Database for Alternative Splicing of Lncrnas Across Human Cancers

IsoformSwitchAnalyzeR: Analysis of changes in genome-wide patterns of alternative splicing and its functional consequences

Improved methods for RNAseq-based alternative splicing analysis

Survey of Programs Used to Detect Alternative Splicing Isoforms from Deep Sequencing Data In Silico

Nanoaspipe: A Transcriptome Analysis And Alternative Splicing Detection Pipeline For Minion Long-Read Rna-Seq

A general definition and nomenclature for alternative splicing events

ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers

Detecting Tissue-Specific Regulation of Alternative Splicing As a Qualitative Change in Microarray Data.

How to choose the optimal RNA-Seq library characteristics for alternative splicing analysis

Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq

betAS: intuitive analysis and visualization of differential alternative splicing using beta distributions

OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers

: intuitive analysis and visualisation of differential alternative splicing using beta distributions

junctionCounts: comprehensive alternative splicing analysis and prediction of isoform-level impacts to the coding sequence

Alternative splicing regulatory network reconstruction from exon array data.